FDA inspection
Wanbang Biopharmaceuticals: FDA inspection ending May 10, 2019
FDA inspection 1092722 · No Action Indicated (NAI) · Xuzhou
Key facts
| Inspection ID | 1092722 |
|---|---|
| Firm | Wanbang Biopharmaceuticals |
| FEI number | 3007836611 |
| Address | No. 6 Yangshan Road, Jinshanqiao Economic Zone |
| City | Xuzhou |
| Fiscal year | 2019 |
| Inspection end date | May 10, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data